Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSIW) Return on Assets (2022 - 2025)

TriSalus Life Sciences' Return on Assets history spans 4 years, with the latest figure at 1.09% for Q4 2025.

  • For Q4 2025, Return on Assets rose 8.0% year-over-year to 1.09%; the TTM value through Dec 2025 reached 1.09%, up 8.0%, while the annual FY2025 figure was 1.32%, 9.0% down from the prior year.
  • Return on Assets reached 1.09% in Q4 2025 per TLSIW's latest filing, down from 1.02% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.19% in Q4 2022 to a low of 3.23% in Q2 2023.
  • Average Return on Assets over 4 years is 1.65%, with a median of 1.72% recorded in 2023.
  • Peak YoY movement for Return on Assets: tumbled -185bps in 2023, then soared 199bps in 2025.
  • A 4-year view of Return on Assets shows it stood at 0.19% in 2022, then tumbled by -997bps to 2.04% in 2023, then soared by 43bps to 1.17% in 2024, then increased by 6bps to 1.09% in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Return on Assets are 1.09% (Q4 2025), 1.02% (Q3 2025), and 0.89% (Q2 2025).